Italian biotech Cassiopea has won US approval for Winlevi, a topical therapy it says is the first new approach to treating acne in nearly 40 years. An androgen receptor inhibitor, Winlevi ...

A full review of what it was like for two patients with darker skin to take isotretinoin—and what happened after they went ...

However, daily dose was not predictive of acne recurrence and benefits of a higher cumulative dose were not seen beyond 220mg/kg. Results are published in JAMA Dermatology. "These findings support ...

Medically reviewed by Peter Weiss, MD Some women have testosterone levels that are higher than normal, often due to polycystic ovary syndrome (PCOS), ovarian cancer, glandular disorders, or unknown ...

PCOS-related acne falls under the hormonal acne umbrella. While this term isn’t an official medical diagnosis, dermatologists ...

Teen Vogue turned to board-certified dermatologists to learn all about acne, one of the most common symptoms of “second ...

The scene is both hot and scary, and the spit at the center of it, shocking to some, is real. The Sinners spit was, for better and worse, a conversation starter, especially once an anonymous person ...

Acne Paper’s return with Issue 20 reaffirms its position as a unique voice in the publishing world, offering a thoughtful and unhurried counterpoint to the rapid pace of digital media.

Hong Kong biotech Ascletis is planning to file a new oral treatment for acne for approval in China soon, on the back of new phase 3 data that suggests it could be a big step forward in treatment ...

In axolotls, retinoic acid acts like a molecular GPS. Its concentration changes along the length of a regenerating limb, ...

Discover how stem cells may help reduce acne scars by boosting collagen, improving skin texture, and speeding up healing—plus what the research says. Stem Cell Therapy for Acne Scars: Treatment ...

Sagimet Bioscience’s denifanstat, a one-daily pill for the treatment of acne, has succeeded in a Phase III trial, with the biotech’s license partner Ascletis Bioscience set to submit the drug ...